Affinage

HEXIM2

Protein HEXIM2 · UniProt Q96MH2

Length
286 aa
Mass
32.4 kDa
Annotated
2026-04-28
15 papers in source corpus 8 papers cited in narrative 7 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

HEXIM2 is a paralog of HEXIM1 that, together with 7SK snRNA, assembles into a large ribonucleoprotein complex containing a HEXIM dimer (homodimer or HEXIM1–HEXIM2 heterodimer) and two P-TEFb (CDK9–Cyclin T) molecules, thereby sequestering P-TEFb in an inactive state and inhibiting CDK9 kinase activity (PMID:15713662, PMID:15965233). HEXIM2 preferentially associates with Cyclin T2 over Cyclin T1 and binds importin alpha with higher affinity than HEXIM1, implicating it in the nuclear import of Cyclin T subunits (PMID:19883659). When HEXIM1 is depleted, HEXIM2 functionally compensates to maintain P-TEFb inhibition, although transcriptional feedback selectively upregulates HEXIM1 but not HEXIM2, indicating non-redundant regulatory wiring despite overlapping biochemical function (PMID:15713662, PMID:24515107).

Mechanistic history

Synthesis pass · year-by-year structured walk · 5 steps
  1. 2005 High

    Identification of HEXIM2 as a second 7SK-binding P-TEFb inhibitor established that P-TEFb regulation is not solely dependent on HEXIM1 and revealed built-in redundancy in CDK9 control.

    Evidence Glycerol gradient, IP, EMSA, in vitro kinase assay, and siRNA knockdown in human cell lines by two independent groups

    PMID:15713661 PMID:15713662

    Open questions at the time
    • Structural basis for how HEXIM2 contacts CDK9 was not resolved
    • Tissue-specific expression differences between HEXIM1 and HEXIM2 not addressed
    • No in vivo (animal model) confirmation of compensatory relationship
  2. 2005 High

    Determination that HEXIM1 and HEXIM2 form homo- and heterodimers via C-terminal domains, and that the large 7SK snRNP contains one HEXIM dimer, one 7SK molecule, and two P-TEFb units, defined the stoichiometry of the inactive complex.

    Evidence Yeast two-hybrid, gel-permeation chromatography, chemical cross-linking, glycerol gradient sedimentation, and mutational analysis

    PMID:15965233 PMID:15994294

    Open questions at the time
    • Relative abundance of HEXIM2 homodimers versus heterodimers in cells was not quantified
    • No high-resolution structure of the full complex
    • Mechanism by which dimerization is required for P-TEFb inhibition not established
  3. 2007 Medium

    Discovery that hnRNP proteins (A1, A2, Q, R) bind 7SK RNA and facilitate dissociation of the HEXIM–P-TEFb complex revealed the release mechanism that reactivates P-TEFb upon transcription stress.

    Evidence IP of 7SK-associated proteins, siRNA knockdown of hnRNPs, glycerol gradient sedimentation in human cells

    PMID:17709395

    Open questions at the time
    • Whether hnRNPs preferentially displace HEXIM2- versus HEXIM1-containing complexes was not tested
    • Signal transduction pathway linking transcription inhibition to hnRNP engagement of 7SK is unknown
  4. 2009 High

    Quantitative binding measurements revealed HEXIM2 preferentially binds Cyclin T2 and importin alpha with higher affinity than HEXIM1, suggesting paralog-specific P-TEFb subunit selectivity and a role in nuclear import of Cyclin T.

    Evidence Isothermal titration calorimetry and EMSA with purified recombinant proteins

    PMID:19883659

    Open questions at the time
    • Functional consequence of Cyclin T2 preference for gene-specific transcription was not tested
    • In vivo validation of importin alpha-mediated Cyclin T nuclear import via HEXIM2 is lacking
  5. 2014 Medium

    Demonstration that P-TEFb release selectively upregulates HEXIM1 but not HEXIM2 transcription uncovered an asymmetric feedback loop, implying that HEXIM2 levels are regulated independently of P-TEFb activity.

    Evidence ChIP-seq, luciferase reporter assays, and siRNA knockdown of super elongation complex components in human cells

    PMID:24515107

    Open questions at the time
    • Transcriptional regulators of HEXIM2 expression remain unidentified
    • Physiological contexts in which HEXIM2-specific regulation becomes critical are unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • Open question: what are the non-redundant physiological roles of HEXIM2 versus HEXIM1, particularly given HEXIM2's Cyclin T2 preference and distinct transcriptional regulation?
  • No Hexim2 knockout animal model phenotype reported in the timeline
  • No genome-wide identification of genes specifically regulated by HEXIM2-containing 7SK complexes
  • High-resolution structure of HEXIM2 in complex with 7SK and P-TEFb is unavailable

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0003723 RNA binding 3 GO:0098772 molecular function regulator activity 3
Localization
GO:0005634 nucleus 1
Complex memberships
7SK snRNPP-TEFb·HEXIM·7SK complex

Evidence

Reading pass · 7 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2005 HEXIM2, like HEXIM1, associates with 7SK snRNA and P-TEFb to form an inactive complex; in conjunction with 7SK, HEXIM2 inhibits P-TEFb kinase activity. When HEXIM1 is knocked down, HEXIM2 functionally compensates to maintain P-TEFb inhibition. Glycerol gradient analysis, immunoprecipitation, EMSA, in vitro kinase assay, siRNA knockdown The Journal of biological chemistry High 15713661 15713662
2005 HEXIM1 and HEXIM2 form stable homo- and hetero-oligomers (dimers) mediated by their C-terminal domains, and this multimeric state is maintained within the P-TEFb·HEXIM·7SK complex. Yeast two-hybrid, transfection assays, glycerol gradient ultracentrifugation, gel-permeation chromatography, chemical cross-linking The Journal of biological chemistry High 15713661 15965233 15994294
2005 The large inactive P-TEFb complex contains a dimer of HEXIM1 or HEXIM2, one 7SK RNA molecule, and two P-TEFb molecules. The first 172 nucleotides of 7SK are sufficient to bind HEXIM2 and recruit/inhibit P-TEFb. Mutational analysis, glycerol gradient sedimentation, immunoprecipitation, stoichiometric analysis The Journal of biological chemistry High 15965233
2005 HEXIM2 co-expression inhibits HIV Tat transactivation, paralleling HEXIM1, consistent with HEXIM2 sequestering P-TEFb away from Tat. Transfection/co-expression assay, reporter gene assay Retrovirology Medium 15992410
2007 P-TEFb is inactivated upon binding to HEXIM2 (or HEXIM1) proteins associated with 7SK; dissociation of this complex occurs upon transcription inhibition and is facilitated by hnRNPs A1, A2, Q, and R binding to 7SK RNA. Immunoprecipitation of 7SK-associated proteins, siRNA knockdown of hnRNPs, glycerol gradient sedimentation Molecular and cellular biology Medium 17709395
2009 Hexim2 binds Cyclin T2 with higher affinity than Cyclin T1 (and conversely Hexim1 prefers Cyclin T1), and both Hexim1 and Hexim2 interact with importin alpha (Kd ~0.5 µM for Hexim2 vs ~2.0 µM for Hexim1), suggesting a collaborative nuclear import pathway for Cyclin T via Hexim proteins. Isothermal titration calorimetry (ITC), electrophoretic mobility shift assay (EMSA) with radiolabeled 7SK snRNA Journal of molecular biology High 19883659
2014 Release of P-TEFb from the 7SK snRNP (containing HEXIM1 or HEXIM2) leads to increased transcription of HEXIM1 (but not HEXIM2) from a proximal promoter, indicating a feedback loop that maintains P-TEFb equilibrium. ChIP-seq, luciferase reporter assay, siRNA knockdown of superelongation complex components (AFF4, ELL2) The Journal of biological chemistry Medium 24515107

Source papers

Stage 0 corpus · 15 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2005 Analysis of the large inactive P-TEFb complex indicates that it contains one 7SK molecule, a dimer of HEXIM1 or HEXIM2, and two P-TEFb molecules containing Cdk9 phosphorylated at threonine 186. The Journal of biological chemistry 183 15965233
2011 7SK snRNA: a noncoding RNA that plays a major role in regulating eukaryotic transcription. Wiley interdisciplinary reviews. RNA 147 21853533
2007 Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR. Nucleic acids research 132 17576689
2005 HEXIM2, a HEXIM1-related protein, regulates positive transcription elongation factor b through association with 7SK. The Journal of biological chemistry 102 15713662
2007 The transcription-dependent dissociation of P-TEFb-HEXIM1-7SK RNA relies upon formation of hnRNP-7SK RNA complexes. Molecular and cellular biology 93 17709395
2005 Compensatory contributions of HEXIM1 and HEXIM2 in maintaining the balance of active and inactive positive transcription elongation factor b complexes for control of transcription. The Journal of biological chemistry 89 15713661
2005 Transcription-dependent association of multiple positive transcription elongation factor units to a HEXIM multimer. The Journal of biological chemistry 50 15994294
2014 Release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein (snRNP) activates hexamethylene bisacetamide-inducible protein (HEXIM1) transcription. The Journal of biological chemistry 48 24515107
2007 HEXIM1 is a promiscuous double-stranded RNA-binding protein and interacts with RNAs in addition to 7SK in cultured cells. Nucleic acids research 43 17395637
2005 Inhibition of Tat activity by the HEXIM1 protein. Retrovirology 34 15992410
2005 siRNA depletion of 7SK snRNA induces apoptosis but does not affect expression of the HIV-1 LTR or P-TEFb-dependent cellular genes. Journal of cellular physiology 31 16152622
2009 Specificity of Hexim1 and Hexim2 complex formation with cyclin T1/T2, importin alpha and 7SK snRNA. Journal of molecular biology 26 19883659
2021 Identification and validation of RNA-binding protein-related gene signature revealed potential associations with immunosuppression and drug sensitivity in glioma. Cancer medicine 22 34482648
2025 Exploring Potential Drug Targets in Multiple Cardiovascular Diseases: A Study Based on Proteome-Wide Mendelian Randomization and Colocalization Analysis. Cardiovascular therapeutics 6 40026415
2023 Study of the Genetic Expression of Antiretroviral Restriction Factors and Acute Phase Proteins in Cattle Infected with Bovine Leukemia Virus. Pathogens (Basel, Switzerland) 2 37111415